Media & Stories | Boehringer Ingelheim
Media & Stories
Boehringer Ingelheim’s hub for providing you with the latest press releases, news, background stories, and further press material for download.
Press Releases
[European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF](/content/human-health/lung-diseases/pulmonary-fibrosis/european-commission-approves-jascayd-novel-treatment-ipf-ppf "European Commission approves JASCAYD novel treatment IPF PPF"/index.html)
July 17, 2026
European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF
[Read more](/content/human-health/lung-diseases/pulmonary-fibrosis/european-commission-approves-jascayd-novel-treatment-ipf-ppf "Read more about "European Commission approves JASCAYD®, well-tolerated, novel oral treatment for IPF and PPF""/index.html)
[Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II](/content/human-health/crm-health/metabolic-health/obesity-potential-first-class-triple-receptor-agonist-phase-2 "Obesity potential first-in-class triple receptor agonist Phase 2"/index.html)
July 16, 2026
Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II
[Read more](/content/human-health/crm-health/metabolic-health/obesity-potential-first-class-triple-receptor-agonist-phase-2 "Read more about "Boehringer strengthens obesity pipeline as potential first-in-class triple receptor agonist enters Phase II""/index.html)
[Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2026 "Boehringer Ingelheim half-year results 2026"/index.html)
July 15, 2026
Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches
[Read more](/content/about-us/who-we-are/boehringer-ingelheim-half-year-results-2026 "Read more about "Boehringer reports first-half 2026 sales growth, driven by JARDIANCE® and product launches""/index.html)
Newsbits
[Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico](/content/about-us/sustainable-development/boehringer-fund-backs-healthcare-innovators-africa-mexico "boehringer-fund-backs-healthcare-innovators-africa-mexico"/index.html)
July 09, 2026
Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico
[Read more](/content/about-us/sustainable-development/boehringer-fund-backs-healthcare-innovators-africa-mexico "Read more about "Boehringer Ingelheim Social Engagement Fund backs healthcare innovators in East Africa and Mexico""/index.html)
[Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published](/content/human-health/cancer/lung-cancer/study-results-zongertinib-her2-mutant-advanced-nsclc-published-nejm "Study results zongertinib HER2-mutant advanced NSCLC published NEJM"/index.html)
April 16, 2026
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published
[Read more](/content/human-health/cancer/lung-cancer/study-results-zongertinib-her2-mutant-advanced-nsclc-published-nejm "Read more about "Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published""/index.html)
[Three investments mark a strong finish to 2025 for Social Engagement Fund](/content/about-us/sustainable-development/2025-africa-investments-social-engagement-fund "2025 Africa investments Social Engagement Fund"/index.html)
March 17, 2026
Three investments mark a strong finish to 2025 for Social Engagement Fund
[Read more](/content/about-us/sustainable-development/2025-africa-investments-social-engagement-fund "Read more about "Three investments mark a strong finish to 2025 for Social Engagement Fund""/index.html)
Stories
Empowering patients to lead change
Patient Partnership
Empowering patients to lead change
Our commitment to evidence-based patient advocacy with patient experience data (PED) and patient participation in healthcare decision-making.
[Read more](/content/human-health/patients/patient-partnership/empowering-patients-advocate-patient-experience-data-ped "Read more about "Empowering patients to lead change""/index.html)
[Is this the end of the paper leaflets?](/content/human-health/patients/patient-safety/electronic-product-information-end-paper-leaflets "Electronic product information: Is this the end of the paper leaflets?"/index.html)
Patient Safety & Pharmacovigilance
Is this the end of the paper leaflets?
Enhancing access to medical information for patients.
[Read more](/content/human-health/patients/patient-safety/electronic-product-information-end-paper-leaflets "Read more about "Is this the end of the paper leaflets?""/index.html)
[Saving lives by breaking silos](/content/human-health/crm-health/metabolic-health/holistic-crm-care-saving-lives-breaking-silos "Holistic CRM care: Saving lives by breaking silos"/index.html)
Metabolic Health
Saving lives by breaking silos
A call for integrated care in tackling some of the most devastating conditions, by Shashank Deshpande, Chairman of the Board of Managing Directors
[Read more](/content/human-health/crm-health/metabolic-health/holistic-crm-care-saving-lives-breaking-silos "Read more about "Saving lives by breaking silos""/index.html)
Media Contacts
Harro Ten Wolde
Head of Global Media Relations
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Tereza Urbankova
Senior Media Relations Manager
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Mark Valentiner
Senior Media Relations Manager
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-170136
Valerie-Chiara Nestle
Media Relations Manager
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (7351) 54-175075
Heidi De Wit-Sommerfeld
Head of Animal Health Communications
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799
Liza Konz
Head of Innovations Unit Communications
E-Mail:
press@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-174201
Current Events
Please check back later!
There are no upcoming events in the near future.
Past Events
[Annual Press Conference 2026](/content/about-us/annual-press-conference-2026 "Annual Press Conference 2026"/index.html)
About us
Annual Press Conference 2026
- March 25, 2026
- 10:30
- Ingelheim, Germany and online
[Annual Press Conference 2025](/content/about-us/annual-press-conference-2025 "Annual Press Conference 2025"/index.html)
About us
Annual Press Conference 2025
- April 2, 2025
- 10:30
- Ingelheim, Germany and online
[Save the Date! Transforming Science Day: 2025](/content/science-innovation/human-health-innovation/heidelberg-transforming-science-day-2025 "Heidelberg Transforming Science Day 2025"/index.html)
Human Health Innovation
Save the Date! Transforming Science Day: 2025
- February 25, 2025
- 1:00 - 6:00 p.m. CET
- Heidelberg, Germany